Taimur Khan, Washington State University Tri-Cities, United States Reviewed by Keith Dana Thomsen, Lawrence Livermore National Laboratory (DOE), United States Sandeep Kondakala, National Center for Toxicological Research (FDA), United States Updates Copyright 2024 Hashim, Arif, Tabassum, Rehman, Bajaj, Sirohi and Khan
For mothers who choose to breastfeed and pursue metabolic treatment simultaneously, PlexusDx works with prescribing providers to explore lower-dose microdose GLP-1 protocols or oral formulations as a cautious middle ground, always under close maternal and infant monitoring
July 10, 2021
Both drugs are GLP-1 receptor agonists , which induce insulin production and suppress glucagon secretion depending on blood glucose levels
L-Carnitine is administered as an intramuscular injection, typically 2-3 times per week depending on your licensed clinician's recommendation